Swissmedic, the Swiss Agency for Therapeutic Products, approved Novartis AG’s (NYSE:NVS) Coartem (artemether-lumefantrine) Baby on Tuesday. This marks the first malaria medicine specifically approved ...
The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday. The drug, known as Coartem Baby or Riamet ...
But if a permanent tooth comes out, it’s a dental emergency that requires swift action. Permanent teeth have the best chance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback